Key result
D-dimer <275 ng/mL safely excludes PE irrespective of clinical probability.
Why the study?
Does a quantitative latex-agglutination D-dimer assay alone safely exclude pulmonary embolism without the need for clinical risk stratification in patients presenting to emergency departments?
Observational (n=376)
Does a quantitative latex-agglutination D-dimer assay alone safely exclude pulmonary embolism without the need for clinical risk stratification in patients presenting to emergency departments?
A quantitative latex-agglutination D-dimer assay with a threshold of <275 ng/mL may safely exclude pulmonary embolism without the need for clinical risk stratification.
Answers are grounded in this paper and cite their sources.
Supports D-dimer <275 ng/mL for ruling out PE in ED patients; leaves open prospective validation before practice change.
Clinical risk stratification and D-dimer assay can be of use in excluding pulmonary embolism in patients presenting to emergency departments but many D-dimer assays exist and their accuracy varies. We used clinical risk stratification combined with a quantitative latex-agglutination D-dimer assay to screen patients before arranging further imaging if required. Retrospective analysis of a sequential series of 376 patients revealed that no patient with a D-dimer of <275 ng/mL was diagnosed with pulmonary embolism, irrespective of clinical probability. We conclude that a latex-agglutination assay could be used to exclude pulmonary embolism without the necessity for clinical risk stratification. If these findings are borne out by further work, D-dimer strategies to exclude pulmonary embolism could substantially reduce imaging workload.
No takes yet. Share an insight, caveat, or question.
Christopher Hammond (2005) conducted an observational in Pulmonary embolism (n=376). Quantitative latex-agglutination D-dimer assay <275 ng/mL was evaluated on Diagnosis of pulmonary embolism. A quantitative latex-agglutination D-dimer assay level of <275 ng/mL excluded pulmonary embolism in all patients (0 cases diagnosed), irrespective of clinical probability.
Synapse has enriched 10 related papers. Consider them for comparative context: